MDLN
Medline Inc. Class A Common Stock
NASDAQ: MDLN · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$39.25
-2.44% today
Updated 2026-06-05
Market cap
$30.23B
P/E ratio
31.36
P/S ratio
1.04x
EPS (TTM)
$1.14
Dividend yield
—
52W range
$33 – $51
Volume
9.2M
WallStSmart proprietary scores
55
out of 100
Grade: C+
Hold
Investment rating
7.3
Growth
B+6.5
Quality
B5.5
Profitability
C+4.7
Valuation
C4/9
Piotroski F-Score
Moderate
1.8
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →202 stocks currently score above 75
Price targets
Analyst target
$50,480.00
+128511.46%
12-Month target
$53.34
+35.90%
Intrinsic (DCF)
—
Margin of safety
—
6 Strong Buy17 Buy5 Hold0 Sell0 Strong Sell
Price chart
Stock snapshot
Strengths
+ Free cash flow $316.00M — positive
+ Revenue growth 10.70% QoQ
Risks
- Altman Z 1.79 — distress zone
- Thin margins at 3.32%
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM | 2026 (E) |
|---|---|---|---|---|---|---|
| Revenue | $21.45B | $23.23B | $25.51B | $28.43B | $29.14B | $31.5B |
| Net income | $-25.00M | $234.00M | $1.20B | $1.16B | $129.00M | — |
| EPS | — | — | — | — | $1.14 | $1.49 |
| Free cash flow | $-67.00M | $1.40B | $1.41B | $1.30B | $316.00M | — |
| Profit margin | -0.12% | 1.01% | 4.70% | 4.08% | 3.32% | — |
Peer comparison
Smart narrative
Medline Inc. Class A Common Stock trades at $39.25. representing a P/E of 31.36x trailing earnings. Our Smart Value Score of 55/100 indicates the stock is fair. The company scores 4/9 on the Piotroski F-Score. With an Altman Z-Score of 1.79, it sits in the distress. TTM revenue stands at $29.14B. with profit margins at 3.32%.
Frequently asked questions
What is Medline Inc. Class A Common Stock's stock price?
Medline Inc. Class A Common Stock (MDLN) trades at $39.25, on a P/E of 31.4x and a P/S of 1.0x. Those multiples show what the market is paying for each dollar of earnings and sales, which is the real starting point for judging whether the price is reasonable.
Is Medline Inc. Class A Common Stock overvalued?
Medline Inc. Class A Common Stock carries a Smart Value Score of 55/100 (Grade C+), which we rate Hold. That score blends growth, quality, and valuation into one read.
What is the price target of Medline Inc. Class A Common Stock (MDLN)?
The 12-month analyst consensus target is $50,480.00, about 128511.5% above the current $39.25. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.
What is the future stock price of MDLN by 2030?
Our research-backed model puts the 2030 base case at $619.92, built from revenue projections, a growth-adjusted P/S multiple, net debt, and share dilution. It is a scenario rather than a prediction, and the bull and bear cases around it matter more than the single number when you are sizing a position.
What is Medline Inc. Class A Common Stock's revenue?
Medline Inc. Class A Common Stock's trailing twelve-month revenue is $29.14B, and our model projects it reaching about $41.91B by 2030. Revenue scale anchors the valuation multiples and shows whether growth is reaching the top line, so it is best read alongside margin and growth trends to see if that revenue is getting more profitable over time.
Altman Z-Score?
Medline Inc. Class A Common Stock's Altman Z-Score is 1.79, which places it in the distress. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.
Company info
SectorHEALTHCARE
IndustryMEDICAL INSTRUMENTS & SUPPLIES
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio1.04x
ROE8.55%
Beta—
50D MA$42.29
200D MA$43.27
Shares out0.85B
Float0.32B
Short ratio—
Avg volume9.2M
Performance
1 week+0.00%
1 month-7.13%
3 months-18.93%
YTD-19.98%
1 year—
3 years—
5 years—